Managers / Q3 2020 · view latest →
Eversept Partners, LP
CIK 0001697013 · 444 MADISON AVENUE, 22ND FLOOR, NEW YORK, NY, 10022 · 212-271-4200
Reported Value
$445M
Q3 2020
Positions
48
Filings on Record
63
2019–present window
Filed
Nov 13, 2020
amendment (RESTATEMENT)
Summary
Eversept Partners, Lp reported $445M in U.S.-listed holdings across 48 positions for Q3 2020.
Its largest position, Horizon Therapeutics Pub L, represents 10.6% of the portfolio.
Compared with Q2 2020, the fund opened 8 new positions and exited 31.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q3 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.9B | 120 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.0B | 107 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.5B | 86 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.1B | 68 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $985M | 57 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.1B | 65 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.5B | 67 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.5B | 74 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.5B | 70 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.1B | 57 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.2B | 69 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $966M | 71 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.1B | 62 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.08T | 64 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $978M | 69 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.2B | 76 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.2B | 86 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.4B | 105 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.3B | 102 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.3B | 87 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.3B | 83 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $841M | 60 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $445M | 48 | Nov 13, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $619M | 71 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $395M | 65 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $516M | 75 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $320M | 59 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $351M | 64 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $339M | 54 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $181M | 59 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.